Second American Ebola victim arrives in Atlanta

American Ebola patient Nancy Writebol, 59, was wheeled into Emory University Hospital at 1pm on Tuesday by medics wearing hazmat suits. 

She arrived in the United States after being flown overnight from Liberia and will be treated by infectious disease specialists at Emory University Hospital, according to Christian missionary group SIM USA.

She is reportedly in a stable condition after receiving a second-dose of an experimental drug to combat the deadly disease.

She will be in the same isolation ward as Kent Brantly, 33, an Ebola-infected American doctor who was able to walk into the hospital when he arrived by ambulance on Saturday.

The pair, who served on a joint team in Monrovia run by Christian aid groups SIM USA and Samaritan's Purse, are believed to be the first Ebola patients treated in the United States.

Writebol and Brantly returned to the United States separately because the plane equipped to transport them could carry only one patient at a time. Johnson said doctors in Liberia made the decision to send Brantly home first.

The plane carrying Writebol landed Tuesday at Dobbins Air Reserve Base in Georgia, where she was transferred to an ambulance and taken to the hospital. The two paramedics who transported Writebol into the hospital also wore white, full-body biohazard suits to avoid any direct contact with her.

Writebol's arrival came as health officials in New York and Ohio said they had run tests for Ebola on two people who had traveled recently to West Africa.

Bruce Johnson, president of SIM USA, said it was still unknown how Writebol contracted Ebola. A longtime missionary from Charlotte, North Carolina, Writebol had been working for SIM USA as a hygienist who decontaminated protective suits worn by healthcare workers inside an isolation unit at a Monrovia treatment center.

Health officials have said the virus does not pose a significant threat to the American public.

There is no proven cure for the contagious hemorrhagic disease, which has killed nearly 900 people in Africa since February in the worst Ebola outbreak on record. The death rate in the current epidemic is about 60 percent, experts say.

The relief groups have said the condition of each aid worker improved in Liberia after the pair received an experimental drug developed by a San Diego-based private biotech firm and previously tested only in monkeys.